1. Home
  2. DHC vs ELVN Comparison

DHC vs ELVN Comparison

Compare DHC & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Diversified Healthcare Trust of Beneficial Interest

DHC

Diversified Healthcare Trust of Beneficial Interest

HOLD

Current Price

$5.66

Market Cap

1.1B

Sector

Real Estate

ML Signal

HOLD

Logo Enliven Therapeutics Inc.

ELVN

Enliven Therapeutics Inc.

HOLD

Current Price

$25.99

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DHC
ELVN
Founded
1998
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
DHC
ELVN
Price
$5.66
$25.99
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$5.75
$41.00
AVG Volume (30 Days)
1.6M
1.5M
Earning Date
02-24-2026
03-12-2026
Dividend Yield
0.70%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,537,901,000.00
N/A
Revenue This Year
$4.79
N/A
Revenue Next Year
$3.64
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.10
N/A
52 Week Low
$2.00
$13.30
52 Week High
$6.06
$29.98

Technical Indicators

Market Signals
Indicator
DHC
ELVN
Relative Strength Index (RSI) 61.62 64.70
Support Level $5.29 $24.29
Resistance Level $6.06 $28.69
Average True Range (ATR) 0.21 2.58
MACD 0.03 0.64
Stochastic Oscillator 62.50 72.49

Price Performance

Historical Comparison
DHC
ELVN

About DHC Diversified Healthcare Trust of Beneficial Interest

Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. It operates through two segments: Office Portfolio and SHOP. The office portfolio includes medical office properties leased to medical-related businesses and life sciences properties. The SHOP segment runs communities that offer multiple types of residential care, ranging from independent living to nursing services. DHT operates across the United States and the majority of its revenue derives from rents and medical programs. Majority of revenue is from SHOP segment.

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

Share on Social Networks: